JPS41137Y1 - - Google Patents
Info
- Publication number
- JPS41137Y1 JPS41137Y1 JP3555264U JP3555264U JPS41137Y1 JP S41137 Y1 JPS41137 Y1 JP S41137Y1 JP 3555264 U JP3555264 U JP 3555264U JP 3555264 U JP3555264 U JP 3555264U JP S41137 Y1 JPS41137 Y1 JP S41137Y1
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Landscapes
- Optical Transform (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP3555264U JPS41137Y1 (de) | 1964-04-23 | 1964-04-23 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP3555264U JPS41137Y1 (de) | 1964-04-23 | 1964-04-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPS41137Y1 true JPS41137Y1 (de) | 1966-01-07 |
Family
ID=31770600
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP3555264U Expired JPS41137Y1 (de) | 1964-04-23 | 1964-04-23 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS41137Y1 (de) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS59175101U (ja) * | 1983-05-10 | 1984-11-22 | 初谷 秀雄 | 目盛が光る定規 |
| FR2692784A1 (fr) * | 1992-06-24 | 1993-12-31 | Pf Medicament | Utilisation de la guanosine, de ses précurseurs et ses dérivés pour la fabrication de médicaments destinés à traiter les déficits fonctionnels cérébraux. |
-
1964
- 1964-04-23 JP JP3555264U patent/JPS41137Y1/ja not_active Expired
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS59175101U (ja) * | 1983-05-10 | 1984-11-22 | 初谷 秀雄 | 目盛が光る定規 |
| FR2692784A1 (fr) * | 1992-06-24 | 1993-12-31 | Pf Medicament | Utilisation de la guanosine, de ses précurseurs et ses dérivés pour la fabrication de médicaments destinés à traiter les déficits fonctionnels cérébraux. |